Skip to main content
Premium Trial:

Request an Annual Quote

Roche, Swiss Non-profit Team to Study IVD Use in Developing Countries

NEW YORK (GenomeWeb News) — Roche Diagnostics will work with the Foundation for Innovative New Diagnostics to study the potential uses of in vitro diagnostics for “poverty related” diseases, the groups said today.
Under the plan, FIND, a Swiss non-profit that promotes health in developing countries, will conduct product evaluation studies with Roche’s help. These programs will attempt to adapt IVD technology to the needs of underprivileged populations, especially those at risk for tuberculosis, sleeping sickness, and malaria.  
FIND CEO Giorgio Roscigno said the group is “hopeful that IVD tools that are efficient, user-friendly, and affordable can significantly increase the quality of diagnosis in these regions.”
FIND is funded by the Bill & Melinda Gates Foundation, the US Agency for International Development, the European Union and the Dutch Government.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.